Analysts Offer Insights on Healthcare Companies: Shire (NASDAQ: SHPG) and Tetraphase (NASDAQ: TTPH)

By Carrie Williams

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Shire (NASDAQ: SHPG) and Tetraphase (NASDAQ: TTPH).

Shire (NASDAQ: SHPG)

In a report released today, Louise Chen from Cantor Fitzgerald assigned a Buy rating to Shire (NASDAQ: SHPG), with a price target of $222. The company’s shares closed yesterday at $132.67, close to its 52-week low of $123.73.

Chen observed:

“Shire reported 4Q17 results and provided its 2018 financial guidance this morning. The report was mixed relative to expectations. Investors that we spoke with were anticipating a strong 4Q17 with no surprises, but hoping for 2018 consensus sales and EPS that would at least bracket consensus (which did not happen).”

According to TipRanks.com, Chen is ranked 0 out of 5 stars with an average return of -10.5% and a 36.1% success rate. Chen covers the Healthcare sector, focusing on stocks such as Aclaris Therapeutics Inc, Sucampo Pharmaceuticals, and ANI Pharmaceuticals Inc.

Currently, the analyst consensus on Shire is Strong Buy and the average price target is $206.25, representing a 55.5% upside.

In a report issued on February 5, RBC Capital also reiterated a Buy rating on the stock with a $192 price target.
Tetraphase (NASDAQ: TTPH)

BMO Capital analyst Ian Somaiya downgraded Tetraphase (NASDAQ: TTPH) to Hold today. The company’s shares closed yesterday at $5.43, close to its 52-week low of $4.91.

According to TipRanks.com, Somaiya is a 5-star analyst with an average return of 12.8% and a 46.9% success rate. Somaiya covers the Healthcare sector, focusing on stocks such as Arbutus Biopharma Corporation, Rocket Pharmaceuticals Inc, and Aeglea Biotherapeutics Inc.

Tetraphase has an analyst consensus of Strong Buy, with a price target consensus of $6.67.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.